Also from this source


You just read:

Ampio Announces Start of Open Label Extension Study to Support Commercial Label of Repeat Administration of Ampion™ in Severe Osteoarthritis of the Knee

News provided by

Ampio Pharmaceuticals, Inc.

Nov 15, 2017, 07:30 ET